Legal Representation
Attorney
Ilene B. Tannen
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 26, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 26, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 30, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 30, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 26, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 26, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 26, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 26, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 19, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 19, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 19, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 19, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 21, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 21, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 21, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 21, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 21, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 21, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 2, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 2, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 2, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 2, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccines; pharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; diagnostic products, preparations and agents for medicinal purposes
Class 042
Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells
Classification
International Classes
005
042